CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Recruiting now · Not applicable
Conditions studied: Chronic Kidney Disease Stage 5, End Stage Renal Disease
In brief
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.
Key facts
- Study ID
- NCT05726526
- Run by
- University of Manitoba
- People needed
- 340
- Starts
- 2022-06-30
- Expected to finish
- 2028-03-30
- Last updated by the study team
- 2026-03-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- >18 years of age
- Patient or primary caregiver can read and speak English
- Patient or patients substitute decision maker is able to provide informed consent
- Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
- Have stage 5 CKD (2 measurements of eGFR <15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation, or have >40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
- Followed in a multidisciplinary CKD clinic
You may not qualify if…
- Inability of self or caregiver assisted self-monitoring using VIEWER
Where it is running
- St. Boniface Hospital — Winnipeg, Manitoba, Canada (enrolling)
- Chronic Disease Innovation Centre, Seven Oaks Hospital — Winnipeg, Manitoba, Canada (enrolling)
- Health Sciences Centre — Winnipeg, Manitoba, Canada (enrolling)
- London Health Sciences Centre — London, Ontario, Canada (enrolling)
- Scarborough Health Network - General Hospital — Scarborough Village, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.